Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Head & Neck 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 255Breast Neoplasms 218Lung Neoplasms 206Glioblastoma 202Head and Neck Neoplasms 193Prostatic Neoplasms 179Squamous Cell Carcinoma of Head and Neck 171Lymphoma 152Rectal Neoplasms 138Esophageal Neoplasms 125Central Nervous System Neoplasms 122Leukemia 111Brain Neoplasms 106Pancreatic Neoplasms 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Gliosarcoma 87Esophageal Squamous Cell Carcinoma 84Sarcoma 82Uterine Cervical Neoplasms 81Lymphoma, Follicular 81Neoplasms 80Lymphoma, Large B-Cell, Diffuse 80Lymphoma, Non-Hodgkin 75Hodgkin Disease 74Glioma 68Burkitt Lymphoma 67Colorectal Neoplasms 66Leukemia, Lymphocytic, Chronic, B-Cell 63Astrocytoma 63Neoplasm Metastasis 60

Interventions

Drug Therapy 3Temozolomide 2Radiotherapy 2Radiosurgery 2Leucovorin 2Irinotecan 2Fluorouracil 2sacubitril and valsartan sodium hydrate drug combination 1icotinib 1dostarlimab 1beta Carotene 1avelumab 1alpha-Tocopherol 1Varenicline 1Tyrosine Kinase Inhibitors 1Trastuzumab 1Tobacco Use Cessation Devices 1Therapeutics 1Thalidomide 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Semen Analysis 1Registries 1Probiotics 1Patient Reported Outcome Measures 1Panitumumab 1Nicotine Chewing Gum 1Myofascial Release Therapy 1Megestrol Acetate 1Lenalidomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Second Primary × Radiotherapy × Clear all
NCT06531629 2024-08-06

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

Peking University First Hospital

Completed
72,408 enrolled
Genitourinary

Kidney Neoplasms, Neoplasms, Second Primary

NCT00400426 2013-06-19

DAHANCA 20 Palliative Radiotherapy for Head and Neck Cancer

University of Aarhus

Phase 2 Completed
100 enrolled
Head & Neck

Head and Neck Neoplasms, Recurrence, Neoplasms, Second Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡